Hans CP, Weisenburger DD, Greiner TC et al (2004) Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray. Blood 103:275–282

Article  CAS  PubMed  Google Scholar 

Andhavarapu S, Crozier JA, Jiang L, Sher T (2014) Mantle cell lymphoma and diffuse large B-cell lymphoma of the testis: a unique case of composite non-Hodgkin lymphoma. Eur J Haematol 93:537–542

Article  PubMed  Google Scholar 

Mohammad F, Garcia G, Kedia S et al (2017) Composite diffuse large b-cell and mantle cell lymphoma: a case report. Cureus 9:e963

PubMed  PubMed Central  Google Scholar 

Campo E, Swerdlow SH, Harris NL et al (2011) The 2008 WHO classification of lymphoid neoplasms and beyond: evolving concepts and practical applications. Blood 117:5019–5032

Article  CAS  PubMed  PubMed Central  Google Scholar 

Jain P, Wang M (2019) Mantle cell lymphoma: 2019 update on the diagnosis, pathogenesis, prognostication, and management. Am J Hematol 94:710–725

Article  PubMed  Google Scholar 

Yamaguchi M, Seto M, Okamoto M et al (2002) De novo CD5+ diffuse large B-cell lymphoma: a clinicopathologic study of 109 patients. Blood 99:815–821

Article  CAS  PubMed  Google Scholar 

Salaverria I, Royo C, Carvajal-Cuenca A et al (2013) CCND2 rearrangements are the most frequent genetic events in cyclin D1(-) mantle cell lymphoma. Blood 121:1394–1402

Article  CAS  PubMed  PubMed Central  Google Scholar 

Vela-Chavez T, Adam P, Kremer M et al (2011) Cyclin D1-positive diffuse large B-cell lymphoma is a post-germinal center-type lymphoma without alterations in the CCND1 gene locus. Leuk Lymphoma 52:458–466

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ek S, Dictor M, Jerkeman M et al (2008) Nuclear expression of the non B-cell lineage Sox11 transcription factor identifies mantle cell lymphoma. Blood 111:800–805

Article  CAS  PubMed  Google Scholar 

Hsiao SC, Cortada IR, Colomo L et al (2012) SOX11 is useful in differentiating cyclin D1-positive diffuse large B-cell lymphoma from mantle cell lymphoma. Histopathology 61:685–693

Article  PubMed  Google Scholar 

Brudno J, Tadmor T, Pittaluga S et al (2016) Discordant bone marrow involvement in non-Hodgkin lymphoma. Blood 127:965–970

Article  CAS  PubMed  PubMed Central  Google Scholar 

Margold M, Seidel S, Kowalski T et al (2021) The value of bone marrow biopsy for staging of patients with primary CNS lymphoma. Neuro Oncol 23:2076–2084

Article  PubMed  PubMed Central  Google Scholar 

Goteri G, Rupoli S, Stramazzotti D et al (2007) Coexistence of two discordant B-cell lymphomas in the skin and lymph node: report of a case with primary cutaneous follicle-center lymphoma and nodal mantle-cell lymphoma. Br J Dermatol 157:629–631

Article  CAS  PubMed  Google Scholar 

Carulli G, Marini A, Ciancia EM et al (2011) Discordant lymphoma consisting of splenic mantle cell lymphoma and marginal zone lymphoma involving the bone marrow and peripheral blood: a case report. J Med Case Rep 5:476

Article  PubMed  PubMed Central  Google Scholar 

Li Q, Jiang L, Wu S et al (2020) Discordant lymphoma consisting of mantle cell lymphoma and angioimmunoblastic T cell lymphoma: homology or heterogeneity? Int J Clin Exp Pathol 13:73–80

PubMed  PubMed Central  Google Scholar 

Oka K, Nagayama R, Iijima S et al (2011) Epstein-Barr virus-associated lymphoproliferative disorder presenting with classical Hodgkin lymphoma and developing as peripheral T-cell lymphoma 9 years later: a case report of composite lymphoma. Pathol Int 61:752–755

Article  PubMed  Google Scholar 

Adu-Poku K, Thomas DW, Khan MK et al (2005) Langerhans cell histiocytosis in sequential discordant lymphoma. J Clin Pathol 58:104–106

Article  CAS  PubMed  PubMed Central  Google Scholar 

Terasawa T, Ohashi H, Utsumi M et al (2003) Case of Epstein-Barr virus-associated transformation of mantle cell lymphoma. Am J Hematol 73:194–199

Article  PubMed  Google Scholar 

Bai Y, Bolger S, Khan S et al (2024) Primary refractory discordant diffuse large B-cell and classical Hodgkin lymphoma. J Hematol 13:238–244

Article  PubMed  PubMed Central  Google Scholar 

Morris PG, Correa DD, Yahalom J et al (2013) Rituximab, methotrexate, procarbazine, and vincristine followed by consolidation reduced-dose whole-brain radiotherapy and cytarabine in newly diagnosed primary CNS lymphoma: final results and long-term outcome. J Clin Oncol 31:3971–3979

Article  CAS  PubMed  PubMed Central  Google Scholar 

Yoon SE, Jo H, Kang ES et al (2022) Role of upfront autologous stem cell transplantation in patients newly diagnosed with primary CNS lymphoma treated with R-MVP: real-world data from a retrospective single-center analysis. Bone Marrow Transplant 57:641–648

Article  CAS  PubMed  Google Scholar 

Soussain C, Choquet S, Blonski M et al (2019) Ibrutinib monotherapy for relapse or refractory primary CNS lymphoma and primary vitreoretinal lymphoma: final analysis of the phase II “proof-of-concept” iLOC study by the Lymphoma study association (LYSA) and the French oculo-cerebral lymphoma (LOC) network. Eur J Cancer 117:121–130

Article  CAS  PubMed  Google Scholar 

Munshi PN, Hamadani M, Kumar A et al (2021) ASTCT, CIBMTR, and EBMT clinical practice recommendations for transplant and cellular therapies in mantle cell lymphoma. Bone Marrow Transplant 56:2911–2921

Article  PubMed  PubMed Central  Google Scholar 

Wang ML, Blum KA, Martin P et al (2015) Long-term follow-up of MCL patients treated with single-agent ibrutinib: updated safety and efficacy results. Blood 126:739–745

Article  CAS  PubMed  PubMed Central  Google Scholar 

Lee JL, Kim S, Kim SW et al (2005) ESHAP plus G-CSF as an effective peripheral blood progenitor cell mobilization regimen in pretreated non-Hodgkin’s lymphoma: comparison with high-dose cyclophosphamide plus G-CSF. Bone Marrow Transplant 35:449–454

Article  CAS  PubMed  Google Scholar 

Koresawa-Shimizu R, Suzuki R, Uehara Y et al (2023) Comparison of MEAM, MCEC and LEED high-dose chemotherapy followed by autologous stem cell transplantation in relapsed/refractory diffuse large B-cell lymphoma: data from the Japan Society for Hematopoietic and Cellular Therapy Registry. Bone Marrow Transplant 59:125–127

Article  PubMed  Google Scholar